New Details on the Revision of USP Chapter 1
Recommendation

16-18 June 2026
Good Engineering Practice for Pharmaceutical Companies and Suppliers
As already reported in the news "Second Revision of USP Chapter <1> Injections and Implanted Drug Products (Parenterals)-Product Quality Tests", USP's Chapter <1> "Injections and Implanted Drug Products (Parenterals)-Product Quality Tests' has been revised again. New information is now available.
The USP published these details on 25 March. The revised version now contains a table of contents for a better overview whereas the Product Performance Test at the end of the Chapter has been deleted. All details about the new version of USP's Chapter <1> can be found on the USP website.
The revised Chapter will become effective on May 1st, 2016.
Related GMP News
03.06.2026Warning Letter regarding serious Deficiencies in Equipment, Documentation and Contamination Control
03.06.2026Questions & Answers on Manual Visual Inspection (MVI)
27.05.2026GMP Deficiencies at a PET Manufacturer
23.04.2026Visual Inspection Group Developments [January through April 2026]
08.04.2026Deficiencies in Equipment Design lead to Warning Letter
01.04.2026Rouging in pharmaceutical Water and Pure Steam Systems: Causes, Effects and Control Measures


